XML 27 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenue $ 1,234,019 $ 937,464 $ 698,099
Cost of revenue 312,523 221,305 177,888
Gross profit 921,496 716,159 520,211
Operating expenses:      
Selling and marketing 506,241 404,209 394,369
Research and development 291,209 238,459 262,177
General and administrative 191,804 157,569 194,287
Total operating expenses 989,254 800,237 850,833
Operating loss (67,758) (84,078) (330,622)
Other income (expense):      
Other (expense) income (2,162) 816 (470)
Interest income 39,402 39,582 24,051
Total other income 37,240 40,398 23,581
Loss before income taxes (30,518) (43,680) (307,041)
Provision for income taxes 1,250 2,462 1,192
Net loss (31,768) (46,142) (308,233)
Comprehensive loss $ (31,768) $ (46,142) $ (308,233)
Net loss per share attributable to Series A and Series B common stockholders, basic (in dollars per share) $ (0.11) $ (0.17) $ (1.27)
Net loss per share attributable to Series A and Series B common stockholders, diluted (in dollars per share) $ (0.11) $ (0.17) $ (1.27)
Weighted average common shares outstanding, basic (in shares) 290,896,895 266,336,826 242,889,272
Weighted average common shares outstanding, diluted (in shares) 290,896,895 266,336,826 242,889,272